KKR-backed JB Chemicals to acquire the portfolio of brands from Sanzyme for $83m.

KKR-backed JB Chemicals, a pharmaceutical products manufacturer, agreed to acquire the portfolio of brands from Sanzyme, a local company engaged in probiotics and reproductive health segments, for $83m. Brands like Sporlac, Lobun, Oxalo, Pubergen, Nano-Leo and Gynogen will be part of JB Chemicals' franchise after the completion of the deal. “The brands being acquired from SPL comprise a range of probiotic, therapeutic nutraceutical and reproductive health products with attractive set of brands for use and exploitation within India," JB Chemicals.